List of TCS ADD Customers
Mumbai, 400 001,
India
Since 2010, our global team of researchers has been studying TCS ADD customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased TCS ADD for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using TCS ADD for Clinical Trial Management include: The Janssen Pharmaceutical Companies of Johnson & Johnson, a United States based Life Sciences organisation with 25000 employees and revenues of $20.00 billion, Tata Translational Cancer Research Centre, a India based Life Sciences organisation with 800 employees and revenues of $200.0 million and many others.
Contact us if you need a completed and verified list of companies using TCS ADD, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The TCS ADD customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Tata Translational Cancer Research Centre | Life Sciences | 800 | $200M | India | Tata Consultancy Services | TCS ADD | Clinical Trial Management | 2016 | n/a |
In 2016 Tata Translational Cancer Research Centre implemented TCS ADD Integrated Data Management IDM as its Clinical Trial Management platform. The deployment uses TCS ADD as the electronic data capture platform to run the Icicle multicentre therapeutic trial and to support clinical database development in India.
Configuration focused on explicit module adoption listed on TTCRC materials, including EDC, terminology management, medical coding, and non-CRF data handling. The implementation encompassed clinical database build and form-level data capture workflows, with data validation and standard coding processes configured through the TCS ADD Integrated Data Management application.
Tata Consultancy Services provides associated clinical data management and analytics services for the study, embedding TCS ADD into operational workflows for clinical data management and analytics teams across the trial sites in India. Operational coverage centers on multicentre trial data capture and regulatory reporting pipelines, aligning the Clinical Trial Management system with study reporting and submission needs.
Governance included centralized module usage and operational handoffs between TTCRC investigational teams and TCS data services, with terminology management and medical coding established to support regulatory reporting. Reported outcomes for the installation include improved data capture and regulatory reporting efficiency as part of the TCS ADD deployment.
|
 |
The Janssen Pharmaceutical Companies of Johnson & Johnson | Life Sciences | 25000 | $20.0B | United States | Tata Consultancy Services | TCS ADD | Clinical Trial Management | 2017 | n/a |
In 2017, The Janssen Pharmaceutical Companies of Johnson & Johnson worked with Tata Consultancy Services to co develop and deploy the Connected Clinical Trials capability within the TCS ADD suite. The engagement moved from pilots to a commercial deployment in 2017 and was led through Janssen Research & Development in the United States, with a focus on strengthening clinical operations.
The TCS ADD Connected Clinical Trials implementation used the CCT Adherence, CCT Label, and CCT Tracking modules to address patient engagement, medication adherence, and clinical supply tracking. Configuration centered on adherence monitoring workflows, electronic labeling for investigational products, and site level tracking of shipments and inventory to support protocol execution.
Operational coverage targeted clinical operations, site coordinators, clinical supply teams, and patient engagement functions within Janssen Research & Development in the United States. The deployment orchestrated data flows and workflow automation across those functional areas to standardize patient communication sequences and supply tracking processes in line with Clinical Trial Management practices.
Governance for the program was structured as a joint Janssen and Tata Consultancy Services delivery to support rapid pilot to commercial rollout in 2017, and module usage including CCT Adherence, CCT Label, and CCT Tracking is explicitly documented in TCS press materials. The implementation narrative emphasizes the TCS ADD application and the Clinical Trial Management category relationship to Janssen clinical operations.
|
Buyer Intent: Companies Evaluating TCS ADD
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||